Form 4: Natera Exec's RSU Vesting & Tax-Related Stock Sales
Insider Transaction Report
Natera's President of Clinical Diagnostics, Solomon Moshkevich, acquired 1,675 shares through RSU vesting and subsequently sold 875 shares to cover tax obligations.
Summary
- Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NTRA), acquired 1,675 shares of common stock on August 12, 2025, through the vesting of Restricted Stock Units (RSUs).
- These RSUs were part of a grant from October 22, 2021, and vested upon the achievement of specific time and business performance criteria.
- Following the vesting, Moshkevich sold 875 shares of common stock on August 14, 2025, to satisfy tax withholding and remittance obligations.
- The sales were executed at weighted average prices of $155.46 for 867 shares and $155.4248 for 8 shares.
- All transactions were conducted under a Rule 10b5-1(c) pre-arranged trading plan.
- After these transactions, Moshkevich beneficially owns 123,859 shares of Natera common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The vesting of RSUs is a positive event for the executive, indicating performance milestones were met. The subsequent sale of shares is purely for tax purposes and not indicative of a negative outlook on the company by the insider, especially given it was pre-planned under Rule 10b5-1.
Positives
- Vesting of 1,675 Restricted Stock Units (RSUs) indicates the achievement of certain business performance criteria and passage of time, reflecting positive company performance or tenure.
- The transactions were conducted under a Rule 10b5-1(c) plan, indicating pre-planned sales not based on immediate insider information.
Negatives
- The sale of 875 shares, although for tax purposes, reduces the insider's direct ownership stake.
Stakeholder Impact
- Shareholders: The sale of shares by an insider, even for tax purposes, slightly increases the float. However, the pre-planned nature (10b5-1) mitigates concerns about insider sentiment. The vesting of RSUs could be seen as a positive sign of executive compensation tied to performance.
- Employees: The RSU vesting demonstrates the company's compensation structure for executives, which may indirectly reflect on broader employee equity programs.
Key Dates
| Date | Description |
|---|---|
| 2021-10-22 | Date Restricted Stock Units (RSUs) covering 10,000 shares were granted to the Reporting Person. |
| 2025-08-12 | Achievement of criteria certified for the vesting of 1,675 RSUs. |
| 2025-08-14 | Sale of 867 shares of common stock at $155.46 to satisfy tax obligations. |
| 2025-08-14 | Sale of 8 shares of common stock at $155.4248 to satisfy tax obligations. |
| 2025-08-15 | Date the Form 4 was signed by Attorney-in-Fact. |
Recommendation
holdThis filing is a routine insider transaction related to RSU vesting and tax obligations, executed under a pre-planned Rule 10b5-1 arrangement. It does not provide new fundamental information about Natera's business operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transaction is expected and does not signal a change in insider sentiment regarding the company's future prospects. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to buy or sell.
Keywords
Natera, NTRA, SEC Form 4, Insider Trading, Stock Vesting, Restricted Stock Units, RSU, Solomon Moshkevich, Officer Transaction, Tax Withholding, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.